/term/debt-to-asset/TSXV:ZYUS ZYUS Life Sciences (TSXV:ZYUS) Debt-to-Asset
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ZYUS Life Sciences Corp (TSXV:ZYUS) » Definitions » Debt-to-Asset

ZYUS Life Sciences (TSXV:ZYUS) Debt-to-Asset : 0.26 (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ZYUS Life Sciences Debt-to-Asset?

ZYUS Life Sciences's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was C$6.57 Mil. ZYUS Life Sciences's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was C$3.30 Mil. ZYUS Life Sciences's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was C$38.22 Mil. ZYUS Life Sciences's debt to asset for the quarter that ended in Mar. 2024 was 0.26.

ZYUS Life Sciences Debt-to-Asset Historical Data

The historical data trend for ZYUS Life Sciences's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ZYUS Life Sciences Debt-to-Asset Chart

ZYUS Life Sciences Annual Data
Trend Dec21 Dec22 Dec23
Debt-to-Asset
- 0.54 0.24

ZYUS Life Sciences Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.59 0.14 0.15 0.24 0.26

Competitive Comparison of ZYUS Life Sciences's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, ZYUS Life Sciences's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ZYUS Life Sciences's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ZYUS Life Sciences's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where ZYUS Life Sciences's Debt-to-Asset falls into.


ZYUS Life Sciences Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

ZYUS Life Sciences's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(6.553 + 3.253) / 41.627
=0.24

ZYUS Life Sciences's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(6.565 + 3.297) / 38.221
=0.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ZYUS Life Sciences  (TSXV:ZYUS) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

ZYUS Life Sciences Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of ZYUS Life Sciences's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

ZYUS Life Sciences (TSXV:ZYUS) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ZYUS Life Sciences Corp (TSXV:ZYUS) » Definitions » Debt-to-Asset
Comparable Companies
TSXV:DB XCNQ:HUGE TSX:CWEB XCNQ:GRIN TSX:MDP TSX:CRDL XCNQ:CXXI XCNQ:MMEN TSX:AVNT XCNQ:ACRG.A.U ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
ZLSCF:USA
Address
407 Downey Road, Unit 204, Saskatoon, SK, CAN, S7N 4L8
Website
https://www.zyus.com
ZYUS Life Sciences Corp is a next-generation life sciences company engaged in scientific research and development in phyto-therapeutics, including cannabinoid and protein-based formulations. It is committed to delivering high-quality standardized therapeutic formulations that comply with Good Manufacturing Practices (GMP) to provide targeted relief for patients in Canada and globally.
Executives
John Michael Hyshka Senior Officer

ZYUS Life Sciences (TSXV:ZYUS) Headlines

No Headlines